How to Apply Your FIRST40 Discount Code
Instant £40 Savings with Code FIRST40
Switching Mounjaro providers has never been more rewarding. Enter discount code FIRST40 at checkout and instantly save £40 on your first order. This brings our 2.5mg Mounjaro pen down to just £129.99 (from £169.99), while our popular Intro Duo bundle drops to £299.99 (from £339.99). The code applies automatically to any first order, making your switch both simple and cost-effective.
Transparent Pricing After Your Discount
After using FIRST40, see exactly what you'll pay: 5mg pens at £159.99 (usual £199.99), 7.5mg at £209.99 (usual £249.99), and 10mg at £229.99 (usual £269.99). Our Progress Duo bundle combining 5mg and 7.5mg pens costs just £369.99 with your first-order discount. Returning customers continue saving £25 on every subsequent order - no complicated loyalty schemes required.
Simple Steps to Switch and Save
Complete our clinical assessment form online, upload your previous Mounjaro prescription or medical records, and enter code FIRST40 during checkout. Our qualified prescribers review applications within 3 working days, or choose express review for 24-hour turnaround. Once approved, your prescription-only Mounjaro ships via tracked delivery from our GPhC-registered pharmacy.
Why Customers Switch to EverydayMeds
Beyond the £40 first-order discount, customers switch for our transparent pricing structure, reliable stock levels, and professional clinical service. Our qualified UK prescribers conduct thorough assessments ensuring Mounjaro remains suitable alongside your reduced-calorie diet and increased physical activity. We maintain consistent supply chains, avoiding treatment interruptions that concern many patients switching providers.
Bundle Options for Extended Treatment
Maximise your FIRST40 discount with our popular bundles. The Intro Trio (2.5mg, 5mg, 7.5mg) drops to £534.99 with your discount code, while the Progress Trio (5mg, 7.5mg, 10mg) costs £634.99. These bundles support dose progression as prescribed, ensuring smooth treatment continuation without reordering individual pens.
